• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲红豆杉提取物治疗的局部反应及其与T淋巴细胞亚群和生活质量的关联。

Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life.

作者信息

Büssing Arndt, Tröger Wilfried, Stumpf Cristina, Schietzel Michael

机构信息

University Witten/Herdecke, Herdecke, Germany.

出版信息

Anticancer Res. 2008 May-Jun;28(3B):1893-7.

PMID:18630477
Abstract

BACKGROUND

In a previous study a decline of T-lymphocyte function was observed within a 6-month period of Viscum album extract (VA-E) application which did not occur in those patients with dose adaptation in response to strong local reactions (LR) or in those with moderate LR. To further investigate the immunological prerequisites of these differences in the VA-E susceptibilities, an analysis was carried out of the pre-existing differences in the tumor patients' lymphocyte subsets, and of whether the LR pattern (none, moderate, strong) might be associated with distinct aspects of the patients' quality of life.

PATIENTS AND METHODS

Seventy-one cancer patients were subcutaneously treated with VA-E (Iscador) at increasing concentrations and their lymphocyte subsets measured by flowcytometry during a 6 month observation period; quality of life was assessed with the HLQ questionnaire.

RESULTS

The occurrence of stronger LR was associated with a primarily higher level of T-cells and their CD4+ T-helper/inducer subset, and CD25+ respectively HLA-DR+ (activated) T-cells. Moreover, counts or proportions of T-cells, CD4+ T-helper/inducer cells and CD8+ CD28+ cytotoxic cells were lower, while the relative proportions of CD8+ CD28- suppressor cells, B- and NK-cells were the highest in the group with moderate LR. In particular, this latter group had a significantly higher quality of life.

CONCLUSION

Our results indicate that the induction of moderate LR in response to VA-E application was associated with better T cell function and quality of life. Extracts from Viscum album (VA-E) are widely used as a

摘要

背景

在之前的一项研究中,观察到在应用欧洲白蜡树提取物(VA-E)的6个月期间,T淋巴细胞功能出现下降,但在那些因强烈局部反应(LR)而进行剂量调整的患者或中度LR患者中未出现这种情况。为了进一步研究这些VA-E易感性差异的免疫前提条件,对肿瘤患者淋巴细胞亚群的预先存在的差异以及LR模式(无、中度、强烈)是否可能与患者生活质量的不同方面相关联进行了分析。

患者和方法

71名癌症患者接受皮下注射不同浓度的VA-E(Iscador)治疗,并在6个月的观察期内通过流式细胞术测量其淋巴细胞亚群;使用HLQ问卷评估生活质量。

结果

较强LR的出现主要与较高水平的T细胞及其CD4 + T辅助/诱导亚群、CD25 +以及HLA-DR +(活化)T细胞相关。此外,T细胞、CD4 + T辅助/诱导细胞和CD8 + CD28 +细胞毒性细胞的计数或比例较低,而在中度LR组中,CD8 + CD28 -抑制细胞、B细胞和NK细胞的相对比例最高。特别是,后一组的生活质量明显更高。

结论

我们的结果表明,对VA-E应用产生中度LR与更好的T细胞功能和生活质量相关。欧洲白蜡树提取物(VA-E)被广泛用作一种

相似文献

1
Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life.欧洲红豆杉提取物治疗的局部反应及其与T淋巴细胞亚群和生活质量的关联。
Anticancer Res. 2008 May-Jun;28(3B):1893-7.
2
Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.用白树提取物治疗的癌症患者中丝裂原刺激的T淋巴细胞进程。
Anticancer Res. 2007 Jul-Aug;27(4C):2903-10.
3
[Development of lymphocyte subsets in tumor patients after subcutaneous administration of mistletoe extracts].[皮下注射槲寄生提取物后肿瘤患者淋巴细胞亚群的变化]
Forsch Komplementarmed. 1999 Aug;6(4):196-204. doi: 10.1159/000021253.
4
Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer.诱导人树突状细胞成熟和激活:槲寄生作为癌症辅助治疗有益作用的潜在机制。
BMC Cancer. 2008 Jun 4;8:161. doi: 10.1186/1471-2407-8-161.
5
Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses.欧洲槲寄生制剂对人树突状细胞成熟和活化以及CD4⁺T细胞反应的不同影响。
Molecules. 2016 Jul 14;21(7):912. doi: 10.3390/molecules21070912.
6
Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.癌症患者中,低剂量与高剂量起始剂量的欧洲白蜡树对免疫相关及药物不良反应的影响
Phytomedicine. 2017 Dec 1;36:54-58. doi: 10.1016/j.phymed.2017.09.004. Epub 2017 Sep 21.
7
Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.槲寄生提取物对自然杀伤细胞的免疫调节作用:临床试验综述
Forsch Komplementmed. 2010 Apr;17(2):63-73. doi: 10.1159/000288702. Epub 2010 Mar 12.
8
Interleukin-6-mediated cell growth in multiple myeloma--a role for Viscum album extracts?
Onkologie. 2005 Aug;28(8-9):387. doi: 10.1159/000087116. Epub 2005 Aug 29.
9
Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.欧洲槲寄生(白果槲寄生)制剂瘤内应用在肿瘤学中的使用及安全性
Integr Cancer Ther. 2015 Mar;14(2):140-8. doi: 10.1177/1534735414563977. Epub 2014 Dec 30.
10
[Immunostimulatory properties of mistletoe extracts and their application in oncology].[槲寄生提取物的免疫刺激特性及其在肿瘤学中的应用]
Postepy Hig Med Dosw (Online). 2014 Oct 23;68:1216-24. doi: 10.5604/17322693.1126850.

引用本文的文献

1
Use and Safety of Viscum album L Applications in Cancer Patients With Preexisting Autoimmune Diseases: Findings From the Network Oncology Study.白木耳在有自身免疫性疾病的癌症患者中的使用和安全性:网络肿瘤学研究的结果。
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419832367. doi: 10.1177/1534735419832367.
2
Preclinical and clinical effects of mistletoe against breast cancer.槲寄生对乳腺癌的临床前及临床效果
Biomed Res Int. 2014;2014:785479. doi: 10.1155/2014/785479. Epub 2014 Jul 20.
3
Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.
草药和针灸治疗乳腺癌姑息治疗和辅助治疗。
Evid Based Complement Alternat Med. 2013;2013:437948. doi: 10.1155/2013/437948. Epub 2013 Jun 12.
4
Adverse drug reactions in a complementary medicine hospital: a prospective, intensified surveillance study.补充医学医院中的药物不良反应:一项前瞻性、强化监测研究。
Evid Based Complement Alternat Med. 2012;2012:320760. doi: 10.1155/2012/320760. Epub 2012 Jan 17.
5
Quality of life and related dimensions in cancer patients treated with mistletoe extract (iscador): a meta-analysis.癌症患者用槲寄生提取物(iscador)治疗的生活质量和相关维度:荟萃分析。
Evid Based Complement Alternat Med. 2012;2012:219402. doi: 10.1155/2012/219402. Epub 2011 Jun 14.